Newron Pharmaceuticals’ add-on schizophrenia treatment improved both positive and negative symptoms as well as severity in patients with the disorder during a phase 2/3 study. The Italian biotech is ...

Researchers review the future of schizophrenia treatment, highlighting TAAR1 agonists, NMDA enhancers, and the gut-brain axis ...

Xanomeline-trospium (KarXT) — a novel therapy that combines a muscarinic receptor agonist with an anticholinergic agent — led to statistically significant and clinically meaningful improvements in ...

Panelists discuss how understanding and managing the full range of schizophrenia symptoms is key to improving long-term patient outcomes. Panelists discuss how schizophrenia presents a wide spectrum ...

Symptoms of schizophrenia, a serious mental disorder that can include hallucinations and delusions, vary greatly from person to person. One common group of schizophrenia symptoms that doesn’t always ...

Theta burst stimulation (TBS) is a non-invasive brain stimulation technique known for modifying human behavior and treating neurological diseases. A group of scientists conducted a systematic review ...